Next Article in Journal
Macrophage Proteomic Profiling Reveals Divergent TLR4-Dependent and -Independent Responses to Kdo2-Lipid A and Lipid IVa
Previous Article in Journal
Boron as a Molecular Architect of Host–Microbiome Symbiosis: Implications for Dysbiosis and Aging-Related Pathologies
Previous Article in Special Issue
Is Exercise Enough? Evidence from Controlled Clinical Trials on Rehabilitation with and Without Adjunct Modalities for Musculoskeletal Disorders
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Surgical Treatment of Juvenile Hip Chondroblastoma Using Mosaicplasty: A Case Report

by
György Márk Hangody
1,*,
László Rudolf Hangody
1,
János Kiss
2,
Miklós Attila Keszég
1,
Gyula Ferenc Szőcs
1 and
László Hangody
1
1
Department of Orthopaedics and Traumatology, Uzsoki Hospital, 1145 Budapest, Hungary
2
Department of Orthopaedics, Semmelweis University, 1085 Budapest, Hungary
*
Author to whom correspondence should be addressed.
Life 2026, 16(5), 752; https://doi.org/10.3390/life16050752
Submission received: 26 March 2026 / Revised: 24 April 2026 / Accepted: 27 April 2026 / Published: 1 May 2026
(This article belongs to the Special Issue Advances in Personalized Management in Orthopedics and Traumatology)

Abstract

Chondroblastoma is a generally benign tumor occurring at a young age; however, its location near a joint and its tendency to recur make the treatment particularly challenging. This is especially true in the case of its occurrence in the hip joint. Surgical removal—curettage—is the primary method, but the remaining defect can be filled with several methods depending on the size of the tumor. The approach to the lesion is another difficulty. There are several available options, but due to the characteristics of the blood supply to the joint, this is a significant risk. In our case, we used an open autologous osteochondral graft transplantation (mosaicplasty) to treat juvenile hip chondroblastoma in a young female patient, for which the ipsilateral knee joint served as the donor area. The patient was followed up for 3 years after surgery, and, in addition to physical examinations, numerous imaging studies were performed to exclude local recurrence or avascular necrosis in the femoral head and to ensure that the congruence of the implanted osteochondral grafts was maintained.
Keywords: chondroblastoma; osteochondral autograft transplantation; mosaicplasty of the hip chondroblastoma; osteochondral autograft transplantation; mosaicplasty of the hip

Share and Cite

MDPI and ACS Style

Hangody, G.M.; Hangody, L.R.; Kiss, J.; Keszég, M.A.; Szőcs, G.F.; Hangody, L. Surgical Treatment of Juvenile Hip Chondroblastoma Using Mosaicplasty: A Case Report. Life 2026, 16, 752. https://doi.org/10.3390/life16050752

AMA Style

Hangody GM, Hangody LR, Kiss J, Keszég MA, Szőcs GF, Hangody L. Surgical Treatment of Juvenile Hip Chondroblastoma Using Mosaicplasty: A Case Report. Life. 2026; 16(5):752. https://doi.org/10.3390/life16050752

Chicago/Turabian Style

Hangody, György Márk, László Rudolf Hangody, János Kiss, Miklós Attila Keszég, Gyula Ferenc Szőcs, and László Hangody. 2026. "Surgical Treatment of Juvenile Hip Chondroblastoma Using Mosaicplasty: A Case Report" Life 16, no. 5: 752. https://doi.org/10.3390/life16050752

APA Style

Hangody, G. M., Hangody, L. R., Kiss, J., Keszég, M. A., Szőcs, G. F., & Hangody, L. (2026). Surgical Treatment of Juvenile Hip Chondroblastoma Using Mosaicplasty: A Case Report. Life, 16(5), 752. https://doi.org/10.3390/life16050752

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop